Hyperuricemia
Conditions
Interventions
Treatment group:Acupuncture
Control group:Benzbromarone
Sponsors
The First Affiliated Hospital of Sun yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Physician diagnosis of hyperuricemia; 2. Aged 18 years to 80 years; 3. Sign the informed consent forms; Obtain informed consent process should comply with GCP requirements.
Exclusion criteria
Exclusion criteria: 1. Secondary hyperuricemia; 2. hemorrhagic tendency: PT>17s, platelet325mg) or other salicylates; 5. Serum creatinine >1.5mg/dL or ALT more than doubles the upper limit of the normal range; 6. Allergic to benzbromarone used in the present study or allergic constitution; 7. Subjects participating other clinical trials within the past three months; 8. Suffering from metabolic disease, endocrine disease and blood coagulation mechanism was abnormal; 9. Doubt or do have alcohol and drug abuse history, or according to the judgment of the researchers, have lower possibility into the group or complicate the group's other lesions, Such as working environment change often easy to cause lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of decline of serum uric acid;24 hour urinary excretion of uric acid inde; | — |
Countries
China
Contacts
Public ContactSun Baoguo
The First Affiliated Hospital of Sun Yat-sen University
Outcome results
None listed